uniQure (QURE) EBITDA Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
uniQure (QURE) EBITDA Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -2,649.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 179,305.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179,305.00 |
| Mar 31, 2026 | 10,935.00 |
| Dec 31, 2025 | -94,386.00 |
| Sep 30, 2025 | 272,857.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 50,790.00 |
| Dec 31, 2024 | -88,135.00 |
| Sep 30, 2024 | 50,346.00 |
| Jun 30, 2024 | -48,136.00 |
| Mar 31, 2024 | 915,341.00 |
| Dec 31, 2023 | -89,888.00 |
| Sep 30, 2023 | -333,240.00 |
| Jun 30, 2023 | -19,767.00 |
| Mar 31, 2023 | 3.17 Mn |
| Dec 31, 2022 | 128,214.00 |
| Sep 30, 2022 | -111,268.00 |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -59,673.00 |
| Dec 31, 2021 | 150,893.00 |
| Sep 30, 2021 | -152,471.00 |